JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A4070 Elvitegravir (GS-9137)

Target: HIV Integrases

Summary: HIV-1 integrase inhibitor,potent

insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
A4071 Fluorouracil (Adrucil)
3 Citation

Target: Thymidylate Synthase

Summary: Antitumor agent;inhibitor of thymidylate synthase

insoluble in EtOH; ≥10.04 mg/mL
A4073 Raltegravir (MK-0518)
1 Citation

Target: integrase

Summary: HIV-1 integrase inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL
A8204 Lopinavir

Summary: HIV protease inhibitor,highly potent

≥31.45 mg/mL
A8203 Ritonavir

Summary: HIV protease inhibitor

≥26 mg/mL
A8201 Amprenavir (agenerase)

Summary: HIV-1 protease inhibitor
A3253 BMS-626529
2 Citation

Target: HIV-1 gp120

Summary: HIV-1 attachment inhibitor

insoluble in H2O; insoluble in EtOH; ≥1.48 mg/mL
B2224 Etravirine (TMC125)

Target: Reverse Transcriptases

Summary: Reverse transcriptase inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.35 mg/mL
A3765 Rilpivirine

Target: reverse transcriptase

Summary: Inhibitor of next-generation nonnucleoside reverse transcriptase

insoluble in H2O; ≥12.25 mg/mL
A3791 Saquinavir mesylate

Summary: HIV Protease Inhibitor